Amylin Pharmaceuticals Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (27)

View All

Latest Posts

About This Stock More About This Stock
Teva Settles Patent Litigation With Astrazeneca, Enters Into License Agreement
Article By: The Fly
Thursday, June 23, 2016 10:57 AM EDT
The settlement allows Teva to commercialize its generic version of BYETTA in the U.S. beginning October 15, 2017 or earlier under certain circumstances.
In this article: TEVA, AZN Also: AMLN
Read
All Posts

Latest Tweets for $AMLN

No tweets yet!

PARTNER HEADLINES